Current pathology model of pancreatic cancer
Markeri tumorali
Detection of Classic Serum Tumor Markers (CSTMs) Group Bene ts to Differential Diagnosis and Disease Assessment of UTUC
Analize medicale: CA indică prezenţa cancerului gastric Cancer gastric markeri tumorali
Cancers | Free Full-Text | Next-Generation Biomarkers for Cholangiocarcinoma | HTML
Markerii tumorali - Tot ce trebuie să ştii - Cancer360
Abdominal cancer tumor markers, Recommendations
FACTORII DE PROGNOSTIC AI CANCERULUI COLORECTAL (II)
Tumor markers | Fujirebio
Mucins in pancreatic cancer and its microenvironment | Nature Reviews Gastroenterology & Hepatology
Download PDF | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer | Science Translational Medicine
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy | Science Translational Medicine
UNIVERSITATEA “LUCIAN BLAGA” SIBIU FACULTATEA DE MEDICINA “VICTOR PAPILIAN” TEZA DE DOCTORAT IMPORTANTA DIAGNOSTICA, PR
Serum concentrations of CA 242 in patients with various benign (0) and... | Download Scientific Diagram
Cancers | Free Full-Text | Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer | HTML
CA 242 (cancer gastrointestinal)
Analize medicale - Markeri tumorali | Bioclinica
ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile
PDF) Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9
Analize
Oncologie Markeri Tumorali | PDF
ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis | British Journal of Cancer
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) - Digestive and Liver Disease
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
